Browse articles from EyeWorld.org related to the retina. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Complete response letter issued for low-dose atropine drop ➤ Extension study shows reduced GA growth with intravitreal treatment ➤ Durable, 3-year vision improvements seen with optogenetic therapy ➤ Preclinical data supports long-acting nature of investigational anti-VEGF for wet AMD ➤ Company news ➤ ASCRS news and events
➤ FDA approves epithelium-on crosslinking treatment ➤ 12-month results from Phase 1/2 trial evaluating regenerative cell therapy for corneal endothelial disease ➤ Phase 3 data supports nonsteroidal treatment for uveitic macular edema ➤ FDA approves IDE for glaucoma device ➤ Company news ➤ ASCRS news and events
➤ New trifocal receives FDA approval ➤ Robotic system completes its first cataract surgery ➤ Interim results from first-in-human bimatoprost-IOL system ➤ Reproducible regenerative effects observed in preclinical glaucoma model ➤ Phase 3 program begins for intravitreal insert treating wet AMD, DME ➤ ASCRS news and events
➤ Insulin-based treatment for neurotropic keratitis advances ➤ Study evaluating implantable telescope in patients with late-stage AMD begins ➤ Registrational trial to begin for investigational neuroprotective therapy ➤ Enrollment complete in pivotal trials for wet AMD treatment ➤ ASCRS news and events
➤ Priority review granted to possible LHON treatment ➤ Update on drug in development for neuropathic corneal pain ➤ FDA approves generic bimatoprost ➤ Phase 1/2a clinical results for first-in-human retinal pigment epithelial stem cell therapy ➤ Adult dosing complete in trial for X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
➤ Updates on trial and patient experience with artificial cornea ➤ Positive clinical trial update for Usher syndrome type 1B ➤ Positive topline data from Phase 2 study investigating DME and nAMD treatment ➤ First patient dosed in second Phase 3 trial evaluating drop for night vision disturbances ➤ Partnership and company news ➤ ASCRS news and events
➤ New designations granted to investigational treatment for retinal dystrophies ➤ Status update on BLA for bevacizumab for treatment of retinal diseases ➤ Acquisition news ➤ ASCRS news and events
➤ Phase 2 trial is the ‘first and only’ to show vision improvement for Stargardt disease ➤ IND accepted for retinal disease gene therapy and Phase 1/2 trial to begin ➤ First patients dosed in trial evaluating retinitis pigmentosa treatment ➤ LASIK alternative being researched ➤ Partnership news ➤ ASCRS news and events
➤ First gene therapy treatment for macular telangiectasia type 2 performed outside of trial ➤ First patient enrolled in Phase 2b study of ocular micro implant for IOP reduction ➤ Fast Track Designation granted to Stargardt gene therapy ➤ FDA Special Protocol Assessment for non-proliferative diabetic retinopathy trial ➤ IDE granted to new glaucoma therapy system ➤ Partnership news ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.